Get the Stockscreener App
1.34
4.29%
-0.06
After Hours:
1.39
0.05
+3.73%
Compugen Ltd stock is traded at $1.34, with a volume of 631.90K.
It is down -4.29% in the last 24 hours and down -8.84% over the past month.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
See More
Previous Close:
$1.40
Open:
$1.36
24h Volume:
631.90K
Relative Volume:
2.90
Market Cap:
$130.95M
Revenue:
-
Net Income/Loss:
$1.60M
P/E Ratio:
44.67
EPS:
0.03
Net Cash Flow:
$-62.91M
1W Performance:
-6.29%
1M Performance:
-8.84%
6M Performance:
-20.24%
1Y Performance:
-31.63%
1-Day Range:
$1.33
$1.40
1-Week Range:
$1.33
$1.47
52-Week Range:
$1.13
$2.66
Compugen Ltd Stock (CGEN) Company Profile
Compare CGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
1.34 | 130.95M | 0 | 1.60M | -62.91M | 0.03 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-25 | Initiated | Oppenheimer | Outperform |
| Aug-05-22 | Downgrade | Jefferies | Buy → Hold |
| May-26-20 | Resumed | JMP Securities | Mkt Outperform |
| May-13-20 | Initiated | Stifel | Buy |
| May-07-20 | Initiated | SVB Leerink | Outperform |
| Apr-22-20 | Initiated | ROTH Capital | Buy |
| Mar-24-20 | Initiated | SunTrust | Buy |
| Jan-16-20 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-29-18 | Initiated | Oppenheimer | Outperform |
| Feb-01-16 | Resumed | Oppenheimer | Outperform |
| Oct-15-15 | Initiated | FBR Capital | Outperform |
| Apr-23-15 | Resumed | Jefferies | Buy |
| Apr-21-15 | Initiated | Oppenheimer | Outperform |
| Feb-07-14 | Initiated | MLV & Co | Buy |
| Dec-28-09 | Reiterated | Cantor Fitzgerald | Buy |
| Jul-29-09 | Initiated | Cantor Fitzgerald | Buy |
View All
Compugen Ltd Stock (CGEN) Latest News
Visualizing Compugen Ltd. stock with heatmapsJuly 2025 Trends & Real-Time Market Sentiment Alerts - Newser
Top chart patterns to watch in Compugen Ltd.Weekly Investment Report & Growth Oriented Trading Recommendations - Newser
Price action breakdown for Compugen Ltd.July 2025 Levels & Low Risk Entry Point Guides - Newser
News impact scoring models applied to Compugen Ltd.Market Trend Report & Community Verified Watchlist Alerts - Newser
Real time alert setup for Compugen Ltd. performance2025 Historical Comparison & Verified Short-Term Plans - Newser
Applying big data sentiment scoring on Compugen Ltd.July 2025 Reactions & Short-Term High Return Strategies - Newser
Can volume confirm reversal in Compugen Ltd.2025 Valuation Update & Daily Chart Pattern Signals - Newser
Using flow based indicators on Compugen Ltd.Portfolio Growth Summary & Stepwise Trade Execution Plans - Newser
Will a bounce in Compugen Ltd. offer an exit2025 Valuation Update & High Conviction Buy Zone Alerts - Newser
Full technical analysis of Compugen Ltd. stockEarnings Summary Report & Fast Moving Trade Plans - Newser
Price momentum metrics for Compugen Ltd. explained2025 Macro Impact & Weekly Momentum Stock Picks - Newser
What MACD and RSI say about Compugen Ltd.July 2025 Movers & Safe Capital Investment Plans - Newser
Real time breakdown of Compugen Ltd. stock performanceAnalyst Downgrade & Pattern Based Trade Signal System - Newser
How to forecast Compugen Ltd. trends using time seriesEarnings Summary Report & Breakout Confirmation Trade Signals - Newser
Momentum divergence signals in Compugen Ltd. chart2025 EndofYear Setup & Trade Opportunity Analysis - Newser
Is Compugen Ltd. trending in predictive chart modelsJuly 2025 Movers & Comprehensive Market Scan Insights - Newser
Combining machine learning predictions for Compugen Ltd.2025 Stock Rankings & Consistent Profit Alerts - Newser
Analyzing Compugen Ltd. with risk reward ratio chartsWeekly Gains Report & Safe Capital Growth Trade Ideas - Newser
What momentum shifts mean for Compugen Ltd.July 2025 Institutional & Fast Gain Stock Trading Tips - Newser
Pattern recognition hints at Compugen Ltd. upsideWeekly Profit Report & Daily Chart Pattern Signals - Newser
What MACD signals say about Compugen Ltd.Market Sentiment Review & Safe Swing Trade Setup Alerts - Newser
What data driven models say about Compugen Ltd.’s futureJuly 2025 Big Picture & Smart Swing Trading Alerts - Newser
Short Interest in Compugen Ltd. (NASDAQ:CGEN) Declines By 32.6% - MarketBeat
Published on: 2025-09-09 02:01:34 - Newser
How to integrate Compugen Ltd. into portfolio analysis toolsJuly 2025 Breakouts & Reliable Price Breakout Alerts - Newser
Compugen Ltd. stock retracement – recovery analysisJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - Newser
Will Compugen Ltd. price bounce be sustainableQuarterly Portfolio Summary & Low Drawdown Trading Strategies - Newser
Statistical indicators supporting Compugen Ltd.’s strengthJuly 2025 Action & Fast Momentum Stock Entry Tips - Newser
Is Compugen Ltd. still worth holding after the dipEarnings Risk Summary & Real-Time Price Movement Reports - Newser
Compugen Ltd Stock (CGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):